Irish chemical industry news (page 2)

The €40M investment will expand the Grange Castle site, creating 40 jobs and producing the oncology product NINLARO™. Supported by IDA Ireland, it highlights confidence in Ireland's pharma sector.

Evonik's investment supports Vivasure's bioabsorbable arteriotomy closure device, leveraging Evonik's polymer expertise to enhance minimally invasive procedures and patient outcomes.

The new facility, supported by IDA Ireland, represents a €50 million investment and will employ up to 50 people. It has received FDA and Irish regulatory approval.

The new Kilo Scale Facility and Technical Development Laboratory will enhance manufacturing of oncology medicines and improve existing products, reinforcing the Cork site's technical capabilities.

The Cork site will boost LIX® solvent extractant production by Q1 2015 to meet rising demand. New labs in Johannesburg, Shanghai, and Moscow enhance technical service and customer proximity.

The new facility in Roscommon will cost $60-$68M, create 160 construction jobs, and 50 permanent jobs. Supported by IDA Ireland, it marks Jazz's first manufacturing site. Completion expected in 2016.

The Aughinish refinery in Ireland will replace oil-fired boilers with gas-powered steam generators by 2014, enhancing economic and environmental performance amid a broader modernization effort.

The investment will support production of lapatinib for advanced breast cancer treatment, creating up to 150 new jobs at the Currabinny site, established in 1975 and employing over 600 people.